Literature DB >> 7400659

Measurement of bilirubin and its monoconjugates and diconjugates in human serum by alkaline methanolysis and high-performance liquid chromatography.

N Blanckaert, P M Kabra, F A Farina, B E Stafford, L J Marton, R Schmid.   

Abstract

No accurate methods are available for specific determination of unconjugated and conjugated bilirubin. Using a novel approach, we now have developed such an assay which permits direct individual measurement of bilirubin and its isomeric monoconjugates and diconjugates in serum. The monosugar and disugar conjugates are quantitatively converted to the corresponding methyl esters, which are readily extractable into chloroform. These monomethyl and dimethyl esters and unconjugated bilirubin are then separated by HPLC and detected spectrophotometrically in the effluent. Use of an internal standard and calibration of the method with crystalline reference bilirubin and bilirubin methyl esters permit direct measurement of the individual pigment fractions in the sample. The acuracy of this procedure was verified by a radioisotope dilution method. In sera of 22 healthy adults and six patients with Gilbert syndrome, only unconjugated bilirubin was detected. In 42 serum samples of jaundiced patients with hepatobiliary disease, unconjugated and all conjugated bilirubin fractions were increased, with the monoconjugates generally predominating. The total concentration of bilirubin and its carbohydrate conjugates, as determined by the new method, was considerably lower than the TB obtained with conventional diazo procedures. Contrariwise, both the new method and the diazo procedures gave comparable resuts when normal serum enriched with purified bilirubin glucuronides was assayed. Our findings thus indicate that unidentified, diazo-positive compounds distinct from bilirubin and its ester conjugates are present in pathlogical serum samples. The reported asssay is expectd to serve as a reference method for measurement of bilirubin and its carbohydrate conjugates in serum and to find general application in the study of bilirubin metabolism.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7400659

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  19 in total

1.  Serum hepatic biochemical activity in two populations of workers exposed to styrene.

Authors:  C A Brodkin; J D Moon; J Camp; D Echeverria; C A Redlich; R A Willson; H Checkoway
Journal:  Occup Environ Med       Date:  2001-02       Impact factor: 4.402

2.  Hyaluronan secretion into the synovial cavity of rabbit knees and comparison with albumin turnover.

Authors:  P J Coleman; D Scott; J Ray; R M Mason; J R Levick
Journal:  J Physiol       Date:  1997-09-15       Impact factor: 5.182

3.  Radioassay of UDP-glucuronyltransferase-catalysed formation of bilirubin monoglucuronides and bilirubin diglucuronide in liver microsomes.

Authors:  M Vermeir; F Vanstapel; N Blanckaert
Journal:  Biochem J       Date:  1984-10-15       Impact factor: 3.857

4.  Cholestasis.

Authors: 
Journal:  West J Med       Date:  1983-02

5.  Unconjugated bilirubin in hepatic bile with brown pigment gallstones and cholangitis.

Authors:  T Nakano; M Tabata; F Nakayma
Journal:  Dig Dis Sci       Date:  1988-09       Impact factor: 3.199

Review 6.  A review of new approaches to assessing hepatic function in animals.

Authors:  C E Cornelius
Journal:  Vet Res Commun       Date:  1987       Impact factor: 2.459

7.  New method of hepatocyte transplantation and extracorporeal liver support.

Authors:  A A Demetriou; J Whiting; S M Levenson; N R Chowdhury; R Schechner; S Michalski; D Feldman; J R Chowdhury
Journal:  Ann Surg       Date:  1986-09       Impact factor: 12.969

8.  Hepatic disposition and biliary excretion of bilirubin and bilirubin glucuronides in intact rats. Differential processing of pigments derived from intra- and extrahepatic sources.

Authors:  J M Crawford; B J Ransil; C S Potter; S V Westmoreland; J L Gollan
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

9.  Measurement of serum bilirubin and its mono- and diconjugates: application to patients with hepatobiliary disease.

Authors:  B F Scharschmidt; N Blanckaert; F A Farina; P M Kabra; B E Stafford; R A Weisiger
Journal:  Gut       Date:  1982-08       Impact factor: 23.059

10.  Crigler-Najjar syndrome type II. New observation of possible autosomal recessive inheritance.

Authors:  S Güldütuna; U Langenbeck; K W Bock; A Sieg; U Leuschner
Journal:  Dig Dis Sci       Date:  1995-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.